{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-012679","form_type":"8-K","ticker":"EYPT","cik":"0001314102","company_name":"EyePoint, Inc.","filed_at":"2022-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.338328+00:00","generated_at":"2026-06-24T14:50:08.570322+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"EyePoint Pharmaceuticals appoints Karen Zaderej to Board of Directors","bullets":["Karen Zaderej appointed to Board effective July 11, 2022, expanding board to eight members.","She will serve on the Audit Committee; receives $45k annual retainer plus $10k for committee service.","Granted 6,000 RSUs and option for 22,000 shares vesting over three years, exercise price at grant date closing price.","Zaderej is President/CEO/Chair of AxoGen, bringing 35+ years biopharma and medical device experience.","Company expects her insight to advance lead pipeline asset EYP-1901 for wet AMD."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-012679","json":"https://secwatch.observer/filing/0000950170-22-012679.json","markdown":"https://secwatch.observer/filing/0000950170-22-012679.md","text":"https://secwatch.observer/filing/0000950170-22-012679.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314102/000095017022012679/0000950170-22-012679-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314102/000095017022012679/eypt-20220711.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T14:50:08.570322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d4b93c1b96","claim":"Karen Zaderej was appointed as Director at EyePoint, Inc..","evidence_excerpt":"increased the size of the Board to eight members and appointed Karen Zaderej to fill the vacancy on the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1314102/000095017022012679/0000950170-22-012679-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}